Israel’s virus death toll jumps to 101, with 10,743 confirmed cases
The Health Ministry announced late Saturday evening that Israel’s death toll from the coronavirus stood at 101, with five more deaths reported between Saturday morning and night.29-year-old COVID-19 patient treated with Israel's new ‘passive vaccine’
According to Health Ministry figures late Saturday, Israel has 10,743 confirmed coronavirus cases, including 175 in serious condition and 129 people on ventilators.
Another 154 people were in moderate condition, the ministry said Saturday, with the rest having mild symptoms. Close to 7,000 of those diagnosed with the disease are hospitalized at home.
As of Saturday evening, 1,341 have recovered from the illness.
Israeli health officials are expecting a surge in coronavirus deaths in the next 10 days, according to a Friday report.
The rise in deaths does not signify an increase in infections, however. Patients who are already hospitalized and on respirators are likely to succumb to the virus in the coming days, according to predictive models from the Health Ministry, Channel 13 reported.
Almost all of those who have died from COVID-19 in Israel have been elderly and suffered from preexisting conditions, according to hospital officials. The novel coronavirus has been spreading quickly in nursing homes around the country, raising intense concern for the safety of elderly residents.
A 29-year-old haredi (ultra-Orthodox) coronavirus patient who is being treated at Samson Assuta Ashdod University Hospital has improved from serious to serious but stable condition, after receiving multiple doses of plasma over the weekend from a donor who recovered from coronavirus, a spokesperson for the hospital told The Jerusalem Post.Netanyahu-Modi Diplomacy: India Ships Hydroxychloroquine to Israel
On Friday, “with the assistance of Health Minister Ya’acov Litzman and his assistant, a suitable donor, a resident of Jerusalem, was found,” explained MDA director-general Eli Bin.
MDA brought her in an ambulance to its blood service center before Shabbat. A special team was waiting for her and transferred the plasma units to the laboratories to perform all required tests and prepare them for transfusion.
Then, with the approval of the Health Ministry, the blood units were delivered to Assuta and given to the patient.
The man is among the country’s youngest severe patients. He has several underlying medical conditions, and has been hospitalized at Assuta for around a week-and-a-half.
The first patient who recovered from coronavirus donated plasma on April 1, according to MDA deputy director-general of blood services Prof.
Eilat Shinar. Since then, some six other patients have made donations and, in the last two days, plasma units were provided to three different hospitals.
Lifting a blanket export ban, India has shipped a huge consignment of coronavirus treatment drugs to Israel. New Delhi delivered a five-tonne cargo of medicines including chloroquine, the antiviral drug currently being used in the treatment of Wuhan coronavirus.
Prime Minister Benjamin Netanyahu thanked his Indian counterpart, Narendra Modi, for the move. “Thank you, my dear friend, Narendra Modi, Prime Minister of India, for sending hydroxychloroquine to Israel. All the citizens of Israel thank you!” the Israeli leader tweeted on Friday.
New Delhi had previously banned the export of hydroxychloroquine and other coronavirus-related medicines. India is reportedly the biggest manufacturer of the drug typically used in the treatment of malaria patients.
The Times of Israel news website reported New Delhi’s decision:
A plane from India carrying materials used to make medicines for treating coronavirus patients has arrived in Israel.
The five ton shipment, which the Ynet news site said arrived Tuesday, includes ingredients for the drugs hydroxychloroquine and chloroquine, which are used to treat malaria.
Several countries have been experimenting with hydroxychloroquine to treat coronavirus symptoms and US President Donald Trump has touted its potential. Experts, however, have urged caution until bigger trials validate hydroxychloroquine’s effectiveness, as it and chloroquine can have potentially serious side effects, especially in high doses or administered with other medications.